期刊文献+

Toll样受体7、8、9在原发性舍格伦综合征中的表达 被引量:2

Expression of Toll-like receptors 7,8,and 9 in primary Sjgren's syndrome
下载PDF
导出
摘要 目的:检测原发性舍格伦综合征(primary Sjogren’s syndrome,pSS)患者血细胞中Toll样受体(TLR)7、8、9的表达水平,并检测TLR7、9在pSS患者腮腺组织中的表达。方法:采用实时定量PCR,对37例pSS患者和24例对照组患者血细胞中TLR7、8、9的水平进行检测,分析2组之间的差异。应用免疫荧光法和免疫组化分别检测TLR7和TLR9在pSS患者腮腺组织中的表达。应用SAS6.12软件包,对数据进行t检验。结果:实时定量PCR显示,pSS组的TLR7、9的mRNA表达量显著高于对照组,2组之间有显著差异(P<0.05),pSS组的TLR7是对照组的2.17倍,pSS组的TLR9是对照组的2.33倍。而TLR8在2组之间无显著差异(P>0.05)。免疫荧光和免疫组化发现,TLR7、9在pSS组患者腮腺组织中的导管上皮细胞、淋巴细胞和上皮岛均为阳性;而对照组腮腺组织中仅导管上皮细胞为阳性。结论:TLR7和TLR9在原发性舍格伦综合征患者中存在表达异常。 PURPOSE: The purpose of this study was to investigate the level of Toll-like receptors(TLRs) 7,8 and 9 in peripheral blood cells from patients with primary Sjogren's syndrome(pSS) and whether TLR7 and 9 exist in the parotid glands of pSS.METHODS: Peripheral blood cells and parotid gland biopsid specimens from patients with pSS were studied.TLR7,TLR8 and TLR9 gene mRNA levels in peripheral blood cells were determined by using real-time PCR.TLR7-and TLR9-positive cells in parotid glands from 3 pSS patients and 3 controls were observed by using immunofluorescence and immunohistochemistry,respectively.Statistical analysis was performed by Student's t test using SAS 6.12 software package.RESULTS: TLR7 and TLr9 mRNA levels were 2.17-and 2.33-fold higher in pSS patients than control subjects,respectively(P0.05),whereas TLR8 levels were not different between the two groups(P0.05).TLR7-and TLR9-positive cells of the pSS group were localized in the epithelial islands,lymphocytes,and ductal epithelial cells of the parotid glands and were more abundant than the TLR7-and TLR9-positive cells that were only localized in the ductal epithelial cells of parotid glands of control subjects.CONCLUSIONS: TLR7 and TLR9 mRNA levels are up-regulated in the peripheral blood of pSS patients,and TLR7-and TLR9-positive cells exist in the epithelial islands,lymphocytes,and ductal epithelial cells of the parotid glands of individuals affected by pSS,but are limited to the ductal epithelial cells of controls.Supported by Research Fund of Science and Technology Commission of Shanghai Municipality(08DZ271100) and Shanghai Leading Academic Discipline Project(S30206).
出处 《中国口腔颌面外科杂志》 CAS 2011年第2期101-107,共7页 China Journal of Oral and Maxillofacial Surgery
基金 上海市科学技术委员会资助项目(08DZ2271100) 上海市重点学科建设项目(S30206)
关键词 原发性舍格伦综合征 TLR7 TLR8 TLR9 Primary Sjogren's syndrome TLR7 TLR8 TLR9
  • 相关文献

参考文献30

  • 1Venables PJ. Sjǒgren's syndrome[J]. Best Pract Res Clin Rheumatol, 2004,18:313-329. 被引量:1
  • 2Manthorpe R. Sjǒgren's syndrome criteria [J]. Ann Rheum Dis, 2002, 61:482-484. 被引量:1
  • 3Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjǒgren' s syndrome: a revised version of the European criteria proposed by the American-European consensus group [J]. Ann Rheum Dis, 2002, 61:554-558. 被引量:1
  • 4Bolstad AI, Jonsson R. Genetic aspects of Sjǒgren's syndrome[J]. Arthritis Res, 2002,4:353-359. 被引量:1
  • 5Hansen A, Lipsky PE, Dorner T. Immunopathogenesis of primary Sjǒgren's syndrome: implications for disease management and therapy[J]. Curr Opin Rheumatol, 2005,17:558-565. 被引量:1
  • 6Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjǒgren's syndrome[J]. Pro Natl Acad Sci USA, 2006,103:2770-2775. 被引量:1
  • 7Fox RI. Sjǒgren's syndrome[J]. Lancet, 2005, 366:321-331. 被引量:1
  • 8Fox RI, Stern M, Michelson P. Update in Sjǒgren's syndrome[J]. Curr Opin Rheumatol, 2000,12:391-398. 被引量:1
  • 9Takei M, Shiraiwa H, Azuma T, et al. The possible etiopathogenic genes of Sjǒgren's syndrome[J]. Autoimmun Rev, 2005,4:479-484. 被引量:1
  • 10Sugai S. Hepatitis C virus and Sjǒgren's syndrome[J]. Intern Med, 2005, 44:533-535. 被引量:1

同被引文献24

  • 1崔慧娟,唐元家,罗晓兵,邓筠,郭彦芝,黄新芳,陈顺乐,沈南.系统性红斑狼疮患者中miR-146a表达缺陷与I型干扰素通路过度活化相关[J].现代免疫学,2008,28(4):279-284. 被引量:13
  • 2Venables PJ. Sjsgren's syndrome [J]. Best Pracl Res Clio Rheumatol, 2004, 18(3): 313-329. 被引量:1
  • 3Manthorpe R. Sjogren's syndrome criteria [J]. Ann Rheum Dis, 2002, 61(6): 482-484. 被引量:1
  • 4Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group [J]. Ann Rheum Dis, 2002, 61(6): 554-558. 被引量:1
  • 5Bolstad AI, Jonsson R. Genetic aspects of Sjogren's syndrome[J]. Arthritis Res, 2002, 4(6): 353-359. 被引量:1
  • 6Hansen A, Lipsky PE, Darner T. Immunopathogenesis of primary Sjogren's syndrome: implications for disease management and therapy[J]. Curr Opin Rheumatol, 2005, 17(5): 558-565. 被引量:1
  • 7Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome[J]. Pro Natl Acad Sci USA, 2006, 103(8): 2770-2775. 被引量:1
  • 8Fox RI. Sjogren's syndrome[J]. Lancet,2005,366(9482): 321-331. 被引量:1
  • 9Fox RI, Stern M, Michelson P. Update in Sjogren's syndrome[J]. Curr Opin Rheumatol, 2000, 12(5): 391-398. 被引量:1
  • 10Takei M, Shiraiwa H, Azuma T, et al. The possible etiopathogenic genes of Sjogren's syndrome [J]. Autoimmun Rev, 2005, 4(7): 479-484. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部